Advertisement
Original Contribution
JAMA. 2001;285(14):1856-1864. doi: 10.1001/jama.285.14.1856

Cognitive Behavioral Therapy for Treatment of Chronic Primary Insomnia

A Randomized Controlled Trial

  1. Jack D. Edinger, PhD;
  2. William K. Wohlgemuth, PhD;
  3. Rodney A. Radtke, MD;
  4. Gail R. Marsh, PhD;
  5. Ruth E. Quillian, PhD
  1. Author Affiliations: VA Medical Center (Dr Edinger) and Duke University Medical Centers (Drs Edinger, Wohlgemuth, Radtke, Marsh, and Quillian), Durham, NC.

Abstract

Context  Use of nonpharmacological behavioral therapy has been suggested for treatment of chronic primary insomnia, but well-blinded, placebo-controlled trials demonstrating effective behavioral therapy for sleep-maintenance insomnia are lacking.

Objective  To test the efficacy of a hybrid cognitive behavioral therapy (CBT) compared with both a first-generation behavioral treatment and a placebo therapy for treating primary sleep-maintenance insomnia.

Design and Setting  Randomized, double-blind, placebo-controlled clinical trial conducted at a single academic medical center, with recruitment from January 1995 to July 1997.

Patients  Seventy-five adults (n = 35 women; mean age, 55.3 years) with chronic primary sleep-maintenance insomnia (mean duration of symptoms, 13.6 years).

Interventions  Patients were randomly assigned to receive CBT (sleep education, stimulus control, and time-in-bed restrictions; n = 25), progressive muscle relaxation training (RT; n = 25), or a quasi-desensitization (placebo) treatment (n = 25). Outpatient treatment lasted 6 weeks, with follow-up conducted at 6 months.

Main Outcome Measures  Objective (polysomnography) and subjective (sleep log) measures of total sleep time, middle and terminal wake time after sleep onset (WASO), and sleep efficiency; questionnaire measures of global insomnia symptoms, sleep-related self-efficacy, and mood.

Results  Cognitive behavioral therapy produced larger improvements across the majority of outcome measures than did RT or placebo treatment. For example, sleep logs showed that CBT-treated patients achieved an average 54% reduction in their WASO whereas RT-treated and placebo-treated patients, respectively, achieved only 16% and 12% reductions in this measure. Recipients of CBT also showed a greater normalization of sleep and subjective symptoms than did the other groups with an average sleep time of more than 6 hours, middle WASO of 26.6 minutes, and sleep efficiency of 85.1%. In contrast, RT-treated patients continued to report a middle WASO of 43.3 minutes and sleep efficiency of 78.8%.

Conclusions  Our results suggest that CBT represents a viable intervention for primary sleep-maintenance insomnia. This treatment leads to clinically significant sleep improvements within 6 weeks and these improvements appear to endure through 6 months of follow-up.

Related article

« Previous | Next Article »Table of Contents

More in JAMA & Archives Journals